Literature DB >> 26243812

Attenuation of Nitrogen Mustard-Induced Pulmonary Injury and Fibrosis by Anti-Tumor Necrosis Factor-α Antibody.

Rama Malaviya1, Vasanthi R Sunil1, Alessandro Venosa1, Vivianne L Verissimo1, Jessica A Cervelli1, Kinal N Vayas1, LeRoy Hall2, Jeffrey D Laskin3, Debra L Laskin4.   

Abstract

Nitrogen mustard (NM) is a bifunctional alkylating agent that causes acute injury to the lung that progresses to fibrosis. This is accompanied by a prominent infiltration of macrophages into the lung and upregulation of proinflammatory/profibrotic cytokines including tumor necrosis factor (TNF)α. In these studies, we analyzed the ability of anti-TNFα antibody to mitigate NM-induced lung injury, inflammation, and fibrosis. Treatment of rats with anti-TNFα antibody (15 mg/kg, iv, every 9 days) beginning 30 min after intratracheal administration of NM (0.125 mg/kg) reduced progressive histopathologic alterations in the lung including perivascular and peribronchial edema, macrophage/monocyte infiltration, interstitial thickening, bronchiolization of alveolar walls, fibrin deposition, emphysema, and fibrosis. NM-induced damage to the alveolar-epithelial barrier, measured by bronchoalveolar lavage (BAL) protein and cell content, was also reduced by anti-TNFα antibody, along with expression of the oxidative stress marker, heme oxygenase-1. Whereas the accumulation of proinflammatory/cytotoxic M1 macrophages in the lung in response to NM was suppressed by anti-TNFα antibody, anti-inflammatory/profibrotic M2 macrophages were increased or unchanged. Treatment of rats with anti-TNFα antibody also reduced NM-induced increases in expression of the profibrotic mediator, transforming growth factor-β. This was associated with a reduction in NM-induced collagen deposition in the lung. These data suggest that inhibiting TNFα may represent an efficacious approach to mitigating lung injury induced by mustards.
© The Author 2015. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  alveolar macrophages; fibrosis; lung injury; vesicant

Mesh:

Substances:

Year:  2015        PMID: 26243812      PMCID: PMC4659692          DOI: 10.1093/toxsci/kfv161

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  50 in total

1.  Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial.

Authors:  Ganesh Raghu; Kevin K Brown; Ulrich Costabel; Vincent Cottin; Roland M du Bois; Joseph A Lasky; Michiel Thomeer; James P Utz; Rezaul K Khandker; Lawrence McDermott; Saeed Fatenejad
Journal:  Am J Respir Crit Care Med       Date:  2008-07-31       Impact factor: 21.405

2.  Subcutaneous perfusion of tumor necrosis factor induces local proliferation of fibroblasts, capillaries, and epidermal cells, or massive tissue necrosis.

Authors:  P F Piguet; G E Grau; P Vassalli
Journal:  Am J Pathol       Date:  1990-01       Impact factor: 4.307

3.  Levels of cytokine in bronchoalveolar lavage (BAL) fluid in patients with pulmonary fibrosis due to sulfur mustard gas inhalation.

Authors:  Ali Emad; Yasaman Emad
Journal:  J Interferon Cytokine Res       Date:  2007-01       Impact factor: 2.607

4.  N-acetylcysteine abrogates acute lung injury induced by endotoxin.

Authors:  Shang Jyh Kao; David Wang; Hen I Lin; Hsing I Chen
Journal:  Clin Exp Pharmacol Physiol       Date:  2006 Jan-Feb       Impact factor: 2.557

Review 5.  The pharmacology, toxicology, and medical treatment of sulphur mustard poisoning.

Authors:  Mahdi Balali-Mood; Mehrdad Hefazi
Journal:  Fundam Clin Pharmacol       Date:  2005-06       Impact factor: 2.748

Review 6.  Rapid downregulation of innate immune cells, interleukin-12 and interleukin-23 in generalized pustular psoriasis with infliximab in combination with acitretin.

Authors:  M M Tang; Z Spanou; H Tang; F Schibler; N Pelivani; N Yawalkar
Journal:  Dermatology       Date:  2013-01-18       Impact factor: 5.366

7.  Tissue injury by hot fluid containing nitrogen mustard.

Authors:  Guang-Qing Wang; Zhao-Fan Xia
Journal:  Burns       Date:  2007-05-29       Impact factor: 2.744

8.  Induction of neutrophil respiratory burst by tumour necrosis factor-alpha; priming effect of solid-phase fibronectin and intervention of CD11b-CD18 integrins.

Authors:  P Dapino; F Dallegri; L Ottonello; C Sacchetti
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

Review 9.  Role of TNFalpha in pulmonary pathophysiology.

Authors:  Srirupa Mukhopadhyay; John R Hoidal; Tapan K Mukherjee
Journal:  Respir Res       Date:  2006-10-11

Review 10.  Macrophage-mediated inflammation and disease: a focus on the lung.

Authors:  Emily Gwyer Findlay; Tracy Hussell
Journal:  Mediators Inflamm       Date:  2012-12-12       Impact factor: 4.711

View more
  22 in total

Review 1.  Macrophages and inflammatory mediators in pulmonary injury induced by mustard vesicants.

Authors:  Rama Malaviya; Vasanthi R Sunil; Alessandro Venosa; Kinal N Vayas; Rita Businaro; Diane E Heck; Jeffrey D Laskin; Debra L Laskin
Journal:  Ann N Y Acad Sci       Date:  2016-06-28       Impact factor: 5.691

2.  Regulation of Macrophage Foam Cell Formation During Nitrogen Mustard (NM)-Induced Pulmonary Fibrosis by Lung Lipids.

Authors:  Alessandro Venosa; Ley Cody Smith; Alexa Murray; Tanvi Banota; Andrew J Gow; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Sci       Date:  2019-12-01       Impact factor: 4.849

3.  Protective role of spleen-derived macrophages in lung inflammation, injury, and fibrosis induced by nitrogen mustard.

Authors:  Alessandro Venosa; Rama Malaviya; Andrew J Gow; Leroy Hall; Jeffrey D Laskin; Debra L Laskin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-10-16       Impact factor: 5.464

Review 4.  Inflammatory mechanisms of pulmonary injury induced by mustards.

Authors:  Rama Malaviya; Vasanthi R Sunil; Alessandro Venosa; Kinal N Vayas; Diane E Heck; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Lett       Date:  2015-10-23       Impact factor: 4.372

5.  Protective Role of Surfactant Protein-D Against Lung Injury and Oxidative Stress Induced by Nitrogen Mustard.

Authors:  Vasanthi R Sunil; Kinal N Vayas; Jessica A Cervelli; Elena V Ebramova; Andrew J Gow; Michael Goedken; Rama Malaviya; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Sci       Date:  2018-11-01       Impact factor: 4.849

6.  An Official American Thoracic Society Workshop Report: Chemical Inhalational Disasters. Biology of Lung Injury, Development of Novel Therapeutics, and Medical Preparedness.

Authors:  Eleanor M Summerhill; Gary W Hoyle; Sven-Eric Jordt; Bronwen J Jugg; James G Martin; Sadis Matalon; Steven E Patterson; David J Prezant; Alfred M Sciuto; Erik R Svendsen; Carl W White; Livia A Veress
Journal:  Ann Am Thorac Soc       Date:  2017-06

7.  Progressive Lung Injury, Inflammation, and Fibrosis in Rats Following Inhalation of Sulfur Mustard.

Authors:  Rama Malaviya; Elena V Abramova; Raymond C Rancourt; Vasanthi R Sunil; Marta Napierala; Daniel Weinstock; Claire R Croutch; Julie Roseman; Rick Tuttle; Eric Peters; Robert P Casillas; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Sci       Date:  2020-12-01       Impact factor: 4.849

Review 8.  Emerging targets for treating sulfur mustard-induced injuries.

Authors:  Shama Ahmad; Aftab Ahmad
Journal:  Ann N Y Acad Sci       Date:  2016-06-10       Impact factor: 5.691

9.  Role of Macrophages in Acute Lung Injury and Chronic Fibrosis Induced by Pulmonary Toxicants.

Authors:  Debra L Laskin; Rama Malaviya; Jeffrey D Laskin
Journal:  Toxicol Sci       Date:  2019-04-01       Impact factor: 4.849

10.  Lung injury, oxidative stress and fibrosis in mice following exposure to nitrogen mustard.

Authors:  Vasanthi R Sunil; Kinal N Vayas; Elena V Abramova; Raymond Rancourt; Jessica A Cervelli; Rama Malaviya; Michael Goedken; Alessandro Venosa; Andrew J Gow; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2019-10-31       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.